Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2024 · 10-Q
Revenue$660.40M$660.40M−74.2% vs Q2 2023 Net Income-$31.91M-$31.91MN/M vs Q2 2023 EPS Diluted-$0.42-$0.42N/M vs Q2 2023 Gross Profit$544,153,000+4.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$116,149,000−62.9% Free Cash Flowderived$71,767,000−73.1% Margins · derivedGross margin82.4%+62.1 pt vs Q2 2023
Operating margin2.6%+2.1 pt vs Q2 2023
Net margin-4.8%−3.7 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 2, 2024 · 33 d after period end